BDBM105143 US8569281, 168

SMILES CC(C)c1nc(n[nH]1)-c1n[nH]c2ccnc(NC3CCOCC3)c12

InChI Key InChIKey=AUXQFFMCGGOSJT-UHFFFAOYSA-N

Data  2 KI  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 3 hits for monomerid = 105143   

TargetLeucine-rich repeat serine/threonine-protein kinase 2(Human)
Medical Research Council Technology

US Patent
LigandPNGBDBM105143(US8569281, 168)
Affinity DataKi:  7nMAssay Description:This assay was used to determine a compound's potency in inhibiting activity of LRRK2 by determining Kiapp, IC50 or percent inhibition values.More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/24/2014
Entry Details
US Patent

TargetLeucine-rich repeat serine/threonine-protein kinase 2(Human)
Medical Research Council Technology

US Patent
LigandPNGBDBM105143(US8569281, 168)
Affinity DataKi:  7.80nMAssay Description:Inhibition of recombinant human GST-tagged LRRK2 G2019S mutant catalytic domain (970 to 2527 residues) expressed in insect cells using RtGWWRFYTLRRAR...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/19/2021
Entry Details Article
PubMed
TargetLeucine-rich repeat serine/threonine-protein kinase 2(Human)
Medical Research Council Technology

US Patent
LigandPNGBDBM105143(US8569281, 168)
Affinity DataIC50: 35nMAssay Description:Inhibition of LRRK2 G2019S mutant (unknown origin) by cell based assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/19/2021
Entry Details Article
PubMed